where a=0.0002782; b=0.0381529; c=-0.1205126; d=-1.1189533; e - exponent (constant)=2.7; X3 is the concentration of IL-6, pg/ml; X2 is the concentration of soluble formula E of selectin, ng/ml; X1 is the concentration of GTP 1, ng/ml; and with a value of Pe0.29 the presence of endometriopathy is predicted.;EFFECT: increased accuracy and objectivity of assessment of the state of the endometrium in women with reproductive disorders.;3 ex"/> METHOD FOR ENDOMETRIOPATHY PREDICTION IN WOMEN WITH REPRODUCTIVE DISTURBANCES
首页> 外国专利> METHOD FOR ENDOMETRIOPATHY PREDICTION IN WOMEN WITH REPRODUCTIVE DISTURBANCES

METHOD FOR ENDOMETRIOPATHY PREDICTION IN WOMEN WITH REPRODUCTIVE DISTURBANCES

机译:生殖障碍女性子宫内膜病变的预测方法

摘要

FIELD: medicine.;SUBSTANCE: invention is a method for endometriopathy prediction, characterized by determination of the concentration of interleukin-6 (IL-6), glutathione peroxidase-1 (GTP 1) and soluble form of E-selectin in the menstrual blood sample and the coefficient of endometriopathy (P) is determined by formula: where a=0.0002782; b=0.0381529; c=-0.1205126; d=-1.1189533; e - exponent (constant)=2.7; X3 is the concentration of IL-6, pg/ml; X2 is the concentration of soluble formula E of selectin, ng/ml; X1 is the concentration of GTP 1, ng/ml; and with a value of Pe0.29 the presence of endometriopathy is predicted.;EFFECT: increased accuracy and objectivity of assessment of the state of the endometrium in women with reproductive disorders.;3 ex
机译:子宫内膜异位症的预测方法,其特征在于测定经血中白介素-6(IL-6),谷胱甘肽过氧化物酶-1(GTP 1)的浓度和E-选择素的可溶性形式样本和子宫内膜异位症的系数(P)由以下公式确定:其中a = 0.0002782; b = 0.0381529; c = -0.1205126; d = -1.1189533; e-指数(常数)= 2.7; X 3 是IL-6的浓度,pg / ml; X 2 是选择素的可溶性分子式E的浓度,ng / ml; X 1 是GTP 1的浓度,ng / ml;并以P e

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号